Novato, CA, United States of America

Gary N Zecherle



 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gary N. Zecherle

Introduction

Gary N. Zecherle, an accomplished inventor based in Novato, California, has made significant contributions to the field of biotechnology. With a total of three patents to his name, his innovations focus primarily on enzymes that play crucial roles in medical treatments.

Latest Patents

One of Gary N. Zecherle's notable patents is the precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using this enzyme, and the methods for producing and purifying said enzyme. This invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase, including biologically active mutants, fragments, and analogs. His research contributes to the development of pharmaceutical formulations containing this enzyme and presents methods for treating diseases caused by deficiencies in human N-acetylgalactosamine-4-sulfatase, specifically MPS VI. Additionally, Gary's work includes methods for producing and purifying the recombinant precursor enzyme to a highly purified form, further emphasizing the importance of his inventions in medical applications.

Career Highlights

Gary N. Zecherle is affiliated with BioMarin Pharmaceutical Inc., a company renowned for its cutting-edge research in pharmaceuticals and biotechnology. Throughout his career, he has established himself as a leading figure in the development of treatments for rare diseases, focusing on enzymatic therapies that have the potential to transform patient care.

Collaborations

In his endeavors, Gary collaborates with talented individuals like Minmin Qin and Wai-Pan Chan, which highlights the importance of teamwork in scientific research and innovation. These collaborations enable the sharing of expertise and resources, facilitating the advancement of groundbreaking treatments.

Conclusion

In conclusion, Gary N. Zecherle's innovative work in the field of biotechnology, particularly regarding N-acetylgalactosamine-4-sulfatase, demonstrates his commitment to improving medical treatments for those in need. His contributions not only showcase his inventiveness but also illustrate the transformative power of collaboration in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…